DexCom, Inc.

Total Valuation

DexCom, Inc. carries a market capitalization of 28.08B, placing it among publicly traded companies globally. Its enterprise value stands at 23.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

DexCom, Inc. currently has 385.90M shares outstanding.

Valuation Ratios

DexCom, Inc. trades at a trailing price-to-earnings ratio of 26.24. The price-to-sales ratio is 5.07, and the price-to-book ratio stands at 9.27.

Enterprise Valuation

On an enterprise value basis, DexCom, Inc. trades at an EV/EBITDA multiple of 18.09 and an EV/FCF ratio of 10.88. The EV/Sales ratio of 4.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.63 provides insight into valuation relative to core operating earnings.

Financial Position

DexCom, Inc. maintains a current ratio of 1.95, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.83, indicating elevated leverage, while an interest coverage ratio of 77.38 demonstrates strong ability to service its debt obligations.

Financial Efficiency

DexCom, Inc. posts a return on equity of 42.90 and a return on invested capital of 17.22.

Taxes

Over the trailing twelve months, DexCom, Inc. has paid 273.20M in income taxes, reflecting an effective tax rate of 22.70.

Stock Price Statistics

DexCom, Inc.'s stock has declined approximately -14.99825% over the past 52 weeks. The 50-day moving average sits at 64.20, while the 200-day moving average is 67.77.

Income Statement

Over the trailing twelve months, DexCom, Inc. generated 4.82B in revenue and converted that into 930.40M in net income, yielding earnings per share of 2.31. EBITDA reached 1.29B, while operating income came in at 1.03B.

Balance Sheet

DexCom, Inc. holds 2.42B in cash and equivalents against 1.38B in total debt, resulting in a net debt position of 123.60M. Total book value stands at 2.63B, with working capital of 2.11B providing operational flexibility.

Cash Flow

DexCom, Inc. produced 1.78B in operating cash flow over the past twelve months. After subtracting -353.10M in capital expenditures, free cash flow totaled 1.43B - equivalent to 3.68 per share.

Margins

DexCom, Inc. operates with a gross margin of 61.50, reflecting its pricing power and cost economics. The operating margin of 21.45 and net profit margin of 19.31 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

DexCom, Inc.'s most recent stock split took place on June 13, 2022 with a 1:4 split ratio.

Scores

DexCom, Inc. posts an Altman Z-Score of 6.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.